Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...
With reference to Gubra's A/S (CPSE:GUBRA) announcement on March 28, 2025 regarding the satisfaction of the regulatory condition for a license agreement to develop GUB014295, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback